IN10018 in Combination With Dalpiciclib for Progressive Meningiomas

NCT07652762 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Meningioma
CDK4/6 Inhibitor

Interventions

DRUG: Ifebemtinib
DRUG: Dalpiciclib

Sponsor

Capital Medical University